drugset / Trial / NCT02146742

A Study to Assess the Effects of Single Ascending Doses of ASP1707 in Healthy Young Japanese Male Subjects

NCT02146742

Phase 1 Completed 24 enrolled Astellas Pharma Europe B.V.
RandomizedParallel-groupTriple-blindBasic science

Summary

Three groups of 8 Japanese males are given single ascending doses of ASP1707 or placebo to assess the safety and tolerability, and to evaluate how it is absorbed, metabolized and distributed through the body.

Timeline

Start
2011-06
Primary completion
2011-08
Completion
2011-08

Drugs

EvaluationDrugModalityDoseRoute
Subject OPIGOLIX Other / unclassified Oral

Indications

No indication recorded.